Clinical Trials Logo

Birth Weight clinical trials

View clinical trials related to Birth Weight.

Filter by:

NCT ID: NCT00009646 Completed - Infant, Premature Clinical Trials

Trial of Indomethacin Prophylaxis in Preterm Infants (TIPP)

TIPP
Start date: November 1993
Phase: Phase 3
Study type: Interventional

This trial was to determine whether giving low-dose indomethacin to infants weight 500 to 999 grams (approximately 1 to 2 pounds) at birth improves their survival without cerebral palsy or developmental problems at 18 to 22 months of age.

NCT ID: NCT00009620 Completed - Infant, Premature Clinical Trials

Antenatal Phenobarbital to Prevent Neonatal Intracranial Hemorrhage

Phenobarbital
Start date: February 1993
Phase: Phase 3
Study type: Interventional

This large randomized trial tested whether phenobarbital given to a pregnant woman about to deliver a premature infant would prevent brain injuries in their newborns. Women with 24 to 32 week fetuses who were in preterm labor and were expected to deliver within 24 hrs were randomized to phenobarbital or usual care. They were treated until they deliver or the fetus reaches 33 wks gestation. Babies were followed until discharge and evaluated at 18-22 mos corrected age for neurodevelopmental outcome.

NCT ID: NCT00005775 Completed - Sepsis Clinical Trials

Glutamine Supplementation to Prevent Death or Infection in Extremely Premature Infants

Glutamine
Start date: July 1999
Phase: Phase 3
Study type: Interventional

This large multicenter double-masked clinical trial tested whether supplementation of standard neonatal parenteral nutrition with glutamine would reduce the risk of death or late-onset sepsis in extremely-low-birth-weight (ELBW, less than or equal to 1000 gm) infants. Neonates with birth weights of 401-1000gm were randomized to standard TrophAmine or TrophAmine supplemented with glutamine before 72 hours and continued until the infants are tolerating full enteral feedings.